Brief: Arocell Says New Study Shows Clinical Benefit Of UBC Rapid In Detection Of Invasive Bladder Cancer
Aug 22 (Reuters) - AroCell AB (publ) AROC.ST :
* NEW STUDY SHOWS CLINICAL BENEFIT OF UBC RAPID IN DETECTION
OF
INVASIVE BLADDER CANCER
* STUDY INDICATED THAT THE UBC® RAPID TEST EFFECTIVELY
DIFFERENTIATED BETWEEN PATIENTS WITH BLADDER CANCER AND HEALTHY
CONTROLS, BASED ON CYTOKERATIN CONCENTRATIONS
Source text for Eikon: ID:nMFNbNDCR0
Further company coverage: AROC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))